IBDEI0TI ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,13276,2)
;;=^5005856
;;^UTILITY(U,$J,358.3,13277,0)
;;=H40.32X1^^51^632^8
;;^UTILITY(U,$J,358.3,13277,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13277,1,3,0)
;;=3^Traumatic GLC,OS,Mild Stage
;;^UTILITY(U,$J,358.3,13277,1,4,0)
;;=4^H40.32X1
;;^UTILITY(U,$J,358.3,13277,2)
;;=^5005857
;;^UTILITY(U,$J,358.3,13278,0)
;;=H40.32X2^^51^632^9
;;^UTILITY(U,$J,358.3,13278,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13278,1,3,0)
;;=3^Traumatic GLC,OS,Moderate Stage
;;^UTILITY(U,$J,358.3,13278,1,4,0)
;;=4^H40.32X2
;;^UTILITY(U,$J,358.3,13278,2)
;;=^5005858
;;^UTILITY(U,$J,358.3,13279,0)
;;=H40.32X3^^51^632^10
;;^UTILITY(U,$J,358.3,13279,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13279,1,3,0)
;;=3^Traumatic GLC,OS,Severe Stage
;;^UTILITY(U,$J,358.3,13279,1,4,0)
;;=4^H40.32X3
;;^UTILITY(U,$J,358.3,13279,2)
;;=^5133504
;;^UTILITY(U,$J,358.3,13280,0)
;;=H40.32X4^^51^632^11
;;^UTILITY(U,$J,358.3,13280,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13280,1,3,0)
;;=3^Traumatic GLC,OS,Indeterminate Stage
;;^UTILITY(U,$J,358.3,13280,1,4,0)
;;=4^H40.32X4
;;^UTILITY(U,$J,358.3,13280,2)
;;=^5005859
;;^UTILITY(U,$J,358.3,13281,0)
;;=H35.3230^^51^633^25
;;^UTILITY(U,$J,358.3,13281,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13281,1,3,0)
;;=3^Exud AMD,OU,Stage Unspec
;;^UTILITY(U,$J,358.3,13281,1,4,0)
;;=4^H35.3230
;;^UTILITY(U,$J,358.3,13281,2)
;;=^5138528
;;^UTILITY(U,$J,358.3,13282,0)
;;=H35.3231^^51^633^26
;;^UTILITY(U,$J,358.3,13282,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13282,1,3,0)
;;=3^Exud AMD,OU w/ Activ Chrdl Neovas
;;^UTILITY(U,$J,358.3,13282,1,4,0)
;;=4^H35.3231
;;^UTILITY(U,$J,358.3,13282,2)
;;=^5138529
;;^UTILITY(U,$J,358.3,13283,0)
;;=H35.3232^^51^633^27
;;^UTILITY(U,$J,358.3,13283,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13283,1,3,0)
;;=3^Exud AMD,OU w/ Inact Chrdl Neovas
;;^UTILITY(U,$J,358.3,13283,1,4,0)
;;=4^H35.3232
;;^UTILITY(U,$J,358.3,13283,2)
;;=^5138530
;;^UTILITY(U,$J,358.3,13284,0)
;;=H35.3233^^51^633^28
;;^UTILITY(U,$J,358.3,13284,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13284,1,3,0)
;;=3^Exud AMD,OU w/ Inactive Scar
;;^UTILITY(U,$J,358.3,13284,1,4,0)
;;=4^H35.3233
;;^UTILITY(U,$J,358.3,13284,2)
;;=^5138531
;;^UTILITY(U,$J,358.3,13285,0)
;;=H35.3220^^51^633^21
;;^UTILITY(U,$J,358.3,13285,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13285,1,3,0)
;;=3^Exud AMD,OS,Stage Unspec
;;^UTILITY(U,$J,358.3,13285,1,4,0)
;;=4^H35.3220
;;^UTILITY(U,$J,358.3,13285,2)
;;=^5138524
;;^UTILITY(U,$J,358.3,13286,0)
;;=H35.3221^^51^633^22
;;^UTILITY(U,$J,358.3,13286,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13286,1,3,0)
;;=3^Exud AMD,OS w/ Actv Chrdl Neovas
;;^UTILITY(U,$J,358.3,13286,1,4,0)
;;=4^H35.3221
;;^UTILITY(U,$J,358.3,13286,2)
;;=^5138525
;;^UTILITY(U,$J,358.3,13287,0)
;;=H35.3222^^51^633^23
;;^UTILITY(U,$J,358.3,13287,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13287,1,3,0)
;;=3^Exud AMD,OS w/ Inact Chrdl Neovas
;;^UTILITY(U,$J,358.3,13287,1,4,0)
;;=4^H35.3222
;;^UTILITY(U,$J,358.3,13287,2)
;;=^5138526
;;^UTILITY(U,$J,358.3,13288,0)
;;=H35.3223^^51^633^24
;;^UTILITY(U,$J,358.3,13288,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13288,1,3,0)
;;=3^Exud AMD,OS w/ Inactive Scar
;;^UTILITY(U,$J,358.3,13288,1,4,0)
;;=4^H35.3223
;;^UTILITY(U,$J,358.3,13288,2)
;;=^5138527
;;^UTILITY(U,$J,358.3,13289,0)
;;=H35.3210^^51^633^17
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0TI 3801 printed Apr 09, 2024@21:09:08 Page 2
IBDEI0TI ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,13276,2)
+2 ;;=^5005856
+3 ;;^UTILITY(U,$J,358.3,13277,0)
+4 ;;=H40.32X1^^51^632^8
+5 ;;^UTILITY(U,$J,358.3,13277,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,13277,1,3,0)
+8 ;;=3^Traumatic GLC,OS,Mild Stage
+9 ;;^UTILITY(U,$J,358.3,13277,1,4,0)
+10 ;;=4^H40.32X1
+11 ;;^UTILITY(U,$J,358.3,13277,2)
+12 ;;=^5005857
+13 ;;^UTILITY(U,$J,358.3,13278,0)
+14 ;;=H40.32X2^^51^632^9
+15 ;;^UTILITY(U,$J,358.3,13278,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,13278,1,3,0)
+18 ;;=3^Traumatic GLC,OS,Moderate Stage
+19 ;;^UTILITY(U,$J,358.3,13278,1,4,0)
+20 ;;=4^H40.32X2
+21 ;;^UTILITY(U,$J,358.3,13278,2)
+22 ;;=^5005858
+23 ;;^UTILITY(U,$J,358.3,13279,0)
+24 ;;=H40.32X3^^51^632^10
+25 ;;^UTILITY(U,$J,358.3,13279,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,13279,1,3,0)
+28 ;;=3^Traumatic GLC,OS,Severe Stage
+29 ;;^UTILITY(U,$J,358.3,13279,1,4,0)
+30 ;;=4^H40.32X3
+31 ;;^UTILITY(U,$J,358.3,13279,2)
+32 ;;=^5133504
+33 ;;^UTILITY(U,$J,358.3,13280,0)
+34 ;;=H40.32X4^^51^632^11
+35 ;;^UTILITY(U,$J,358.3,13280,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,13280,1,3,0)
+38 ;;=3^Traumatic GLC,OS,Indeterminate Stage
+39 ;;^UTILITY(U,$J,358.3,13280,1,4,0)
+40 ;;=4^H40.32X4
+41 ;;^UTILITY(U,$J,358.3,13280,2)
+42 ;;=^5005859
+43 ;;^UTILITY(U,$J,358.3,13281,0)
+44 ;;=H35.3230^^51^633^25
+45 ;;^UTILITY(U,$J,358.3,13281,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,13281,1,3,0)
+48 ;;=3^Exud AMD,OU,Stage Unspec
+49 ;;^UTILITY(U,$J,358.3,13281,1,4,0)
+50 ;;=4^H35.3230
+51 ;;^UTILITY(U,$J,358.3,13281,2)
+52 ;;=^5138528
+53 ;;^UTILITY(U,$J,358.3,13282,0)
+54 ;;=H35.3231^^51^633^26
+55 ;;^UTILITY(U,$J,358.3,13282,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,13282,1,3,0)
+58 ;;=3^Exud AMD,OU w/ Activ Chrdl Neovas
+59 ;;^UTILITY(U,$J,358.3,13282,1,4,0)
+60 ;;=4^H35.3231
+61 ;;^UTILITY(U,$J,358.3,13282,2)
+62 ;;=^5138529
+63 ;;^UTILITY(U,$J,358.3,13283,0)
+64 ;;=H35.3232^^51^633^27
+65 ;;^UTILITY(U,$J,358.3,13283,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,13283,1,3,0)
+68 ;;=3^Exud AMD,OU w/ Inact Chrdl Neovas
+69 ;;^UTILITY(U,$J,358.3,13283,1,4,0)
+70 ;;=4^H35.3232
+71 ;;^UTILITY(U,$J,358.3,13283,2)
+72 ;;=^5138530
+73 ;;^UTILITY(U,$J,358.3,13284,0)
+74 ;;=H35.3233^^51^633^28
+75 ;;^UTILITY(U,$J,358.3,13284,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,13284,1,3,0)
+78 ;;=3^Exud AMD,OU w/ Inactive Scar
+79 ;;^UTILITY(U,$J,358.3,13284,1,4,0)
+80 ;;=4^H35.3233
+81 ;;^UTILITY(U,$J,358.3,13284,2)
+82 ;;=^5138531
+83 ;;^UTILITY(U,$J,358.3,13285,0)
+84 ;;=H35.3220^^51^633^21
+85 ;;^UTILITY(U,$J,358.3,13285,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,13285,1,3,0)
+88 ;;=3^Exud AMD,OS,Stage Unspec
+89 ;;^UTILITY(U,$J,358.3,13285,1,4,0)
+90 ;;=4^H35.3220
+91 ;;^UTILITY(U,$J,358.3,13285,2)
+92 ;;=^5138524
+93 ;;^UTILITY(U,$J,358.3,13286,0)
+94 ;;=H35.3221^^51^633^22
+95 ;;^UTILITY(U,$J,358.3,13286,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,13286,1,3,0)
+98 ;;=3^Exud AMD,OS w/ Actv Chrdl Neovas
+99 ;;^UTILITY(U,$J,358.3,13286,1,4,0)
+100 ;;=4^H35.3221
+101 ;;^UTILITY(U,$J,358.3,13286,2)
+102 ;;=^5138525
+103 ;;^UTILITY(U,$J,358.3,13287,0)
+104 ;;=H35.3222^^51^633^23
+105 ;;^UTILITY(U,$J,358.3,13287,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,13287,1,3,0)
+108 ;;=3^Exud AMD,OS w/ Inact Chrdl Neovas
+109 ;;^UTILITY(U,$J,358.3,13287,1,4,0)
+110 ;;=4^H35.3222
+111 ;;^UTILITY(U,$J,358.3,13287,2)
+112 ;;=^5138526
+113 ;;^UTILITY(U,$J,358.3,13288,0)
+114 ;;=H35.3223^^51^633^24
+115 ;;^UTILITY(U,$J,358.3,13288,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,13288,1,3,0)
+118 ;;=3^Exud AMD,OS w/ Inactive Scar
+119 ;;^UTILITY(U,$J,358.3,13288,1,4,0)
+120 ;;=4^H35.3223
+121 ;;^UTILITY(U,$J,358.3,13288,2)
+122 ;;=^5138527
+123 ;;^UTILITY(U,$J,358.3,13289,0)
+124 ;;=H35.3210^^51^633^17
